Contenuto

Pubblicazioni Scientifiche dei Ricercatori della Struttura Complessa di Medicina Nucleare (degli ultimi 5 anni)

  1. Bombardieri E., Alessi A., Schillaci O., Crippa F.: La PET nello studio del carcinoma della mammella. Radiol Med 2004; 107(Suppl.2): 33-40
  2. Bombardieri E., Gianni L.: Breast cancer: diagnostic and therapeutic options. Eur J Nucl Med Mol I 2004; 31 (Suppl.1): 1-2
  3. Bombardieri E., Gianni L.: The choice of the correct imaging modality in breast cancer management. Eur J Nucl Med Mol I 2004; 31 (Suppl.1): 179-186
  4. Bombardieri E., Seregni E., Villano C., Chiti A., Bajetta E.: Position of nuclear medicine techniques in the diagnostic work-up of neuroendocrine tumors. Q J Nucl Med 2004; 48: 150-163
  5. Bozzetti F., Gavazzi C., Mariani L., Crippa F.: Glucose-based total parenteral nutrition does not stimulate glucose uptake by humans tumours. Clin Nutrition 2004; 23: 417-421
  6. Buscombe J., Holloway B., Roche N., Bombardieri E.: Position of nuclear medicine modalities in the diagnostic work-up of breast cancer. Q J Nucl Med 2004; 48: 109-118
  7. Casali P., Messina A., Stacchiotti S., Tamborini E., Crippa F., Gronchi A., Orlandi R., Ripamonti C., Spreafico C., Bertieri R., Bertulli R., Colecchia M., Fumagalli E.R., Greco A., Grosso F., Olmi P., Pierotti M.A., Pilotti S.: Imatinib mesylate in chordoma. Cancer 2004; 101: 2086-2097
  8. Crippa F., Gerali A., Alessi A., Agresti R., Bombardieri E.: FDG-PET for axillary lymph node staging in primary breast cancer. Eur J Nucl Med Mol I 2004; 31 (Suppl.1): 97-102
  9. Cuccuru G., Lanzi C., Cassinelli G., Pratesi G., Tortoreto M., Petrangolini G., Seregni E., Martinetti A., Laccabue D., Zanchi C., Zunino F.: Cellular effects and antitumor activity of RET inhibitor RPI-1 on MEN2A-associated medullary thyroid carcinoma. J Natl Cancer Inst 2004; 96: 1006-1014
  10. Ferrari L., Seregni E., Aliberti G., Martinetti A., Pallotti F., Villano C., Lucignani G., Bombardieri E.: Comparative evaluation of two methods to assay thyroglobulin serum concentrations in patients with differentiated thyroid carcinomas. Q J Nucl Med 2004; 48: 237-242
  11. Ferrari L., Seregni E., Lucignani G., Bajetta E., Martinetti A., Aliberti G., Pallotti F., Procopio G., Della Torre S., Luksch R., Bombardieri E.: Accuracy and clinical correlates of two different methods for chromogranin A assay in neuroendocrine tumors. Int J Biol Markers 2004; 19: 295-304
  12. Ferrario E., Ferrari L., Bidoli P., De Candis D., Del Vecchio M., De Dosso S., Buzzoni R., Bajetta E.: Treatment of cancer-related anemia with epoetin alfa: a review. Cancer Treat Rev 2004; 30: 563-575
  13. Fierabracci P., Pinchera A., Tonacchera M., Agretti P., De Marco G., Albertini S., Conforti G., Seregni E., Agresti R., Grasso L., Giani C.: Absence of interference of serum IgGs from patients with breast cancer and thyroid autoimmunity on the function of human iodide symporter gene stably transfected in CHO cells. J Endocrinol Invest 2004; 27: 862-865
  14. Fusi A., Procopio G., Della Torre S., Ricotta R, Bianchini G., Salvioni R., Ferrari L., Martinetti A., Savelli G., Villa S., Bajetta E.: Treatment options in hormone-refractory metastatic prostate carcinoma. Tumori 2004; 90: 535-546
  15. Ishiwata K., Kawamura K., Wang W-F., Furumoto S., Kubota K., Pascali C., Bogni A., Iwata R.: Evaluation of o-[(11)C]methyl-L-tyrosine and o-[(18)F]fluoromethyl-L-tyrosine as tumor imaging tracers by PET. Nucl Med Biol 2004; 31: 191-198
  16. Lind P., Szilvasi I., Pons F., Mansi L., Cuocolo A., Tatsch K., Hoefnagel C., Lewington V., Talbot J.N., Bombardieri E., Britten G., Weestera G., Brook V.: The growing importance of continuing medical education in nuclear medicine: the role of the European School of Nuclear Medicine. Eur J Nucl Med Mol I 2004; 31-B: 23-25
  17. Lucignani G., Bombardieri E.: Assessing anti-cancer treatment by positron emission tomography: primum non nocere. Nucl Med Commun 2004; 25: 429-432
  18. Lucignani G., Bombardieri E.: Molecular imaging: seeing the invisible beyond the "hot spot. Q J Nucl Med 2004; 48: 1-3
  19. Martinetti A., Bajetta E., Ferrari L., Zilembo N., Seregni E., Del Vecchio M., Longarini R., La Torre I., Toffolatti L., Paleari D., Bombardieri E.: Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole. Endocr-Relat Cancer 2004; 11: 771-779
  20. Raspagliesi F., Ditto A., Kusamura S., Fontanelli R., Vecchione F., Maccauro M., Solima E.: Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: A feasibility study. Am J Obstet Gynecol 2004; 191: 435-439
  21. Savelli G., Lucignani G., Seregni E., Marchianò A., Serafini G., Aliberti G., Villano C., Maccauro M., Bombardieri E.: Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours Nucl Med Commun 2004; 25: 445-449
  22. Schillaci O., Bombardieri E.: Medicina nucleare: scintimammografia. Radiol Med 2004; 107(Suppl.2): 41-46
  23. Seregni E., Coli A., Mazzucca N.: Circulating tumour markers in breast cancer. Eur J Nucl Med Mol I 2004; 31(Suppl. 1): 15-22
  24. Zilembo N., Bajetta E., Bichisao E., Martinetti A., La Torre I., Bidoli P., Longarini R., Portale T., Seregni E., Bombardieri E.: The estrogen suppression after sequential treatment with formestane in advanced breast cancer patients. Biomed Pharmacother 2004; 58: 255-259
  25. Bajetta E., Catena L., Procopio G., Bichisao E., Ferrari L., Della Torre S., De Dosso S., Iacobelli S., Buzzoni R., Mariani L., Rosai J.: Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment? Ann Oncol 2005; 16: 1374-1380
  26. Buscombe J.R., Bombardieri E.: Imaging cancer using single photon techniques. Q J Nucl Med Mol Imaging 2005; 49: 121-131
  27. Coliva A., Zacchetti A., Luison E., Tomassetti A., Bongarzone I., Seregni E., Bombardieri E., Martin F., Giussani A., Figini M., Canevari S.: 90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas. Cancer Immunol Immunother 2005; 54: 1200-1213
  28. Huber V., Fais S., Iero M., Lugini L., Canese P., Squarcina P., Zaccheddu A., Colone M., Arancia G., Gentile M., Seregni E., Valenti R., Ballabio G., Belli F., Leo F., Parmiani G., Rivoltini L.: Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology 2005; 128: 1796-1804
  29. Y., Iwata R., Furumoto S., Pascali C., Bogni A., Kubota K., Ishiwaka K.: Simple automated preparation of O-[(11)C]methyl-l-tyrosine for routine clinical use. Appl Radiat Isot 2005; 63: 55-61
  30. Li J., Orlandi R., White C.N., Rosenzweig J., Seregni E., Morelli D., Yu Y., Meng X.Y., Zhang Z., Davidson N.E., Fung E.T., Chan D.W.: Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry. Clin Chem 2005; 51: 2229-2235
  31. R., Podda M.G., Gandola L., Polastri D., Piva L., Castellani M.R., Collini P., Massimino M., Cefalo G., Terenziani M., Ferrari A., Casanova M., Spreafico F., Meazza C., Bozzi F., Marchianò A., Ravagnani F., Fossati Bellani F.: Stage 4 neuroblastoma: sequential hemi-body irradiation or high-dose chemotherapy plus autologous haemopoietic stem cell transplantation to consolidate primary treatment. Br J Cancer 2005; 92: 1984-1988
  32. Maccauro M., Lucignani G., Aliberti G., Villano C., Castellani M.R., Solima E., Bombardieri E.: Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer. Eur J Nucl Med Mol Imaging 2005; 32: 569-574
  33. Maccauro M., Villano C., Aliberti G., Ferrari L., Castellani M.R., Patuzzo R., Tshering D., Santinami M., Bombardieri E.: Lymphoscintigraphy with intraoperative gamma probe sentinel node detection: clinical impact in patients with head and neck melanomas. Q J Nucl Med Mol Imaging 2005; 49: 245-251
  34. Raspagliesi F., Ditto A., Kusamura S., Carcangiu M.L., Vecchione F., Maccauro M., Solima E.: Reply. (letter) (Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: A feasibility study) Am J Obstet Gynecol 2005; 193: 1881-1882
  35. Bajetta E., Procopio G., Catena L., Martinetti A., De Dosso S, Ricci S., Lecchi A.S., Boscani P.F., Iacobelli S., Carteni G., De Braud F., Loli P., Tartaglia A., Bajetta R., Ferrari L.: Lanreotide autogel every 6 weeks compared with Lanreotide microparticles every 3 weeks in patients with well differentiated neuroendocrine tumors: a Phase III Study. Cancer 2006; 107: 2474-2481
  36. Bombardieri E.: The added value of metabolic imaging with FDG-PET in oesophageal cancer: prognostic role and prediction of response to treatment. Eur J Nucl Med Mol Imaging 2006; 33: 753-758
  37. Cascinelli N., Bombardieri E., Bufalino R., Camerini T., Carbone A., Clemente C., Lenisa L., Mascheroni L., Maurichi A., Pennacchioli E., Patuzzo R., Santinami M., Tragni G.: Sentinel and Nonsentinel Node Status in Stage IB and II Melanoma Patients: Two-Step Prognostic Indicators of Survival. J Clin Oncol 2006; 24: 4464-4471
  38. Collini P., Massimino M., Fagundes Leite S., Mattavelli F., Seregni E., Zucchini N., Spreafico F., Ferrari A., Castellani M.R., Cantù G., Fossati Bellani F., Rosai J., for the "Thyroid Cancer Study Group" of the: Istituto Nazionale Tumori of Milan, Italy.: Papillary thyroid carcinoma of childhood and adolescence: a 30-year experience at the Istituto Nazionale Tumori in Milan. Pediatr Blood Cancer 2006; 46: 300-306
  39. Ferrari L., Della Torre S., Collini P., Martinetti A., Procopio G., De Dosso S., Bajetta E., Catena L.: Kit protein (CD117) and proliferation index (Ki-67) evaluation in well and poorly differentiated neuroendocrine tumors. Tumori 2006; 92: 531-535
  40. Massimino M., Collini P., Leite S.F., Spreafico F., Zucchini N., Ferrari A., Mattavelli F., Seregni E., Castellani M.R., Cantù G., Fossati Bellani F., Rosai J., for the "Thyroid Cancer Study Group of the: Istituto Nazionale Tumori of Milan, Italy.: Conservative surgical approach for thyroid and lymph-node involvement in papillary thyroid carcinoma of childhood and adolescence. Pediatr Blood Cancer 2006; 46: 307-313
  41. Mattavelli F., Collini P., Gervasoni C., Pizzi N., Pallotti F., Pastorino U., Thyroid Cancer Study Group of INT Milan: Double, metachronous thyroid metastases of colon cancer. Tumori 2006; 92: 249-251
  42. Procopio G., Ricotta R., Fusi A., Celio L., De Dosso S., Catena L., Ferrari L., Quattrone P., Verzoni E., Bajetta E.: Neuroendocrine tumors of the larynx: a clinical report and literature review. Tumori 2006; 92: 72-75
  43. Angelini P., De Bernardi B., Granata C., Villavecchia G., Morbelli S., Luksch R., Di Cataldo A., Garaventa A., Castellani M.R.: Skeletal involvement in infants with neuroblastoma a quality control attempt. Tumori 2007; 93: 82-87
  44. Baratti D., Kusamura S., Martinetti A., Seregni E., Oliva D.G., Laterza B., Deraco M.: Circulating CA125 in Patients with Peritoneal Mesothelioma Treated with Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion. Ann Surg Oncol 2007; 14: 500-508
  45. Baratti D., Kusamura S., Martinetti A., Seregni E., Laterza B., Oliva D.G., Deraco M.: Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 2007; 14: 2300-2308
  46. Buscombe J., Paganelli G., Burak Z.E., Waddington W., Maublant J., Prats E., Palmedo H., Schillaci O., Maffioli L., Lassmann M., Chiesa C., Bombardieri E., Chiti A.: On behalf of the European Association of Nuclear Medicine Oncology Committee and Dosimetry Committee. Sentinel node in breast cancer procedural guidelines. Eur J Nucl Med Mol Imaging 2007; 34: 2154-2159
  47. Chiesa C., Botta F., Di Betta E., Coliva A., Maccauro M., Aliberti G., Bavusi S., Devizzi L., Guidetti A., Seregni E., Gianni A.M., Bombardieri E.: Dosimetry in myeloablative 90Y-labeled ibritumomab tiuxetan therapy: Possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results. Cancer Biother Radiopharm 2007; 22: 113-120
  48. G., Bardies M., Chiesa C., Monsieurs M., Savolainen S., Strand S.E., Lassmann M.: Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray". Eur J Nucl Med Mol Imaging 2007; 34: 1699-1700
  49. Guzzo M., Quattrone P., Seregni E., Bianchi R., Mattavelli F.: Thyroid carcinoma associated with squamous cell carcinoma of the head and neck: which policy? Head Neck 2007; 29: 33-37
  50. Martinetti A., Ripamonti C., Miceli R., Seregni E., Mariani L., De Conno F., Bajetta E., Bombardieri E.: Short-term effects of pamidronate on bone turnover: Can bone markers be considered predictive of the analgesic response? Oncol Reports 2007; 17: 1533-1540
  51. Massimino M., Gandola L., Collini P., Seregni E., Marchianò A., Serra A., Pignoli E., Spreafico F., Pallotti F., Terenziani M., Biassoni V., Bombardieri E., Fossati Bellani F.: Thyroid-Stimulating Hormone Suppression for Protection Against Hypothyroidism Due to Craniospinal Irradiation for Childhood Medulloblastoma/Primitive Neuroectodermal Tumor. Int J Radiat Oncol Biol Phys 2007; 69: 404-410
  52. Mattavelli F., Bombardieri E., Collini P., Costa L., Pizzi N., Fallahdar D., Pennacchioli E., Santamaria S., Cascinelli N.: Role of surgery in treatment of advanced differentiated thyroid carcinomas. Acta Otorhinolaryngol Ital 2007; 27: 62-67
  53. Ripamonti C., Fagnoni E., Campa T., Seregni E., Maccauro M., Bombardieri E.: Incident pain and analgesic consumption decrease after samarium infusion: a pilot study. Support Care Cancer 2007; 15: 339-342
  54. Tenvall J., Fisher M., Bischof-Delaloye A., Bombardieri E., Bodei L., Giammarile F., Lassmann M., Oyen W., Brans B.: EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with (90)Y-radiolabelled ibritumomab tiuxetan (Zevalin). Eur J Nucl Med Mol Imaging 2007; 34: 616-622
  55. Bodei L., Lam M., Chiesa C., Flux G., Brans B., Chiti A., Giammarile F.: EANM procedure guideline for treatment of refractory metastatic bone pain. Eur J Nucl Med Mol Imaging 2008; 35: 1934-1940
  56. Castellani M.R., Seregni E., Maccauro M., Chiesa C., Aliberti G., Orunesu E., Bombardieri E.: MIBG for diagnosis and therapy of medullay thyroid carcinoma: is there still a role? Q J Nucl Med Mol Imaging 2008; 52: 430-440
  57. Devizzi L., Guidetti A., Tarella C., Magni M., Matteucci P., Seregni E., Chiesa C., Bombardieri E., Di Nicola M., Carlo Stella C., Gianni A.M.: High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation. J Clin Oncol 2008; 26: 5175-5182
  58. Lassmann M., Hanscheid H., Chiesa C., Hindorf C., Flux G., Luster M.: EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: Blood and bone marrow dosimetry in differentiated thyroid cancer therapy Eur J Nucl Med Mol Imaging 2008; 35: 1405-1412
  59. M., Clarke S.E., Dietlein M., Lassmann M., Lind P., Oyen W.J., Tennvall J., Bombardieri E.: Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 2008; 35: 1941-1959
  60. Solima E., Brusati V., Ditto A., Kusamura S., Martinelli F., Hanozet F., Carcangiu M.L., Maccauro M., Raspagliesi F.: Hysteroscopy in endometrial cancer: new methods to evaluate transtubal leakage of saline distension medium. Am J Obstet Gynecol 2008; 198: 214
  61. Zinzani P.L., d'Amore F., Bombardieri E., Brammer C., Codina J.G., Illidge T., Jurczak W., Linkesch W., Morschhauser F., Vandenberghe E., Van Hoff A.: Consensus conference: Implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - Report of a European workshop. Eur J Cancer 2008; 44: 366-373
Ultimo aggiornamento: mercoledì 10 giugno 2009

Menu di approfondimento

accedi al sito www.adobe.com per scaricare la versione freeware di Acrobat Reader

Per visualizzare documenti in formato PDF è necessario Adobe Reader ®.
Scarica la versione gratuita.